Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion type Assertion NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_head.
- NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion wasGeneratedBy ECO_0000203 NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_provenance.
- NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion wasDerivedFrom befree-2016 NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_provenance.
- NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion SIO_000772 24336067 NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_provenance.
- NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion evidence source_evidence_literature NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_provenance.
- NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_assertion description "[Of these target genes, the GADD45A promoter region was shown to be hypermethylated in 82% of wild-type TP53 sarcomas that did not respond to Nutlin-3a, thereby providing mechanistic insight into the innate ability of sarcomas to resist apoptotic death following Nutlin-3a treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1136557.RAt101Vm7eEmNyY_RHgGzknYD-oSNm-ZoCH6Bd4Er2Aqo130_provenance.